Nautilus Biotechnology, Inc. NAUT
Nasdaq · stock · Laboratory Analytical Instruments · website · IPO 2020-08-07
Nautilus Biotechnology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,827,577 | $9.0M | 3.03% |
| CITADEL ADVISORS LLC | 1,934,792 | $3.6M | 1.53% |
| RENAISSANCE TECHNOLOGIES LLC | 690,514 | $1.3M | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 188,730 | $352,925 | 0.15% |
| Point72 Asset Management, L.P. | 67,938 | $127,044 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.